Clinicians and health departments throughout the U.S. should be prepared to detect and manage cases of Middle East respiratory syndrome coronavirus (MERS-CoV), the CDC recently warned.
Recent articles offered differing estimates of the risk of false negatives in testing for SARS-CoV-2, and studies reported the effectiveness of shared ventilators and a cancer drug for patients with severe COVID-19. The FDA revoked its authorization
The benefit of convalescent plasma is uncertain, and hydroxychloroquine did not appear to work for prophylaxis, according to new studies. Experts offered advice on using palliative care, avoiding surgery, changing residency applications, and
The World Health Organization also issued updated information on SARS-CoV-2 transmission.
Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19
Other studies examined transmission of the virus in patients with nonsevere disease and population mobility during the pandemic.
Prone positioning was helpful in patients not on mechanical ventilation, and two very small studies found positive outcomes with drugs used to treat rheumatoid arthritis. ACP members can join a bulk purchase of N95s and gowns.
Trials offered inconclusive evidence about remdesivir, a pilot study found benefits to prone self-positioning for ED patients, and other research quantified the risk of QT prolongation with hydroxychloroquine and azithromycin and provided
As we feared, Buena Vista County, Iowa, made headlines in late May and early June with the dubious honor of having the highest new COVID-19 case rate in the nation.
This is the first pandemic caused by a coronavirus. And we have never before seen a pandemic that can be controlled, at the same time,” said WHO Director-General Tedros Adhanom ... The numbers fell short of those calculations. barely. Montefiore's